Tag Archives: Voltaren

Green light for proposed acquisition

The ACCC will not oppose GSK’s proposed acquisition of Pfizer’s consumer healthcare business in Australia. GSK and Pfizer supply prescription and over-the-counter medications including the well-known pain management products Panadol, Voltaren and Advil, as well as gastrointestinal and cold and flu products. The proposed acquisition combines only their over-the-counter businesses. …

Read More »

Global JV deal by GSK-Pfizer

GlaxoSmithKline (GSK) and Pfizer have announced that they have entered into an agreement to create a premier global consumer healthcare company with robust iconic brands. The boards of directors of both companies have unanimously approved the transaction under which Pfizer will contribute its consumer healthcare business to GlaxoSmithKline’s existing consumer …

Read More »